Sign for Notice Everyday    Sign Up| Sign In| Link| English|

Our Sponsors

    Receive Latest News

    Feedburner
    Share Us


    Effective Responses to FDA 483’s and Warning Letters

    View: 176

    Website https://www.demystifiedsolutions.com/trainingDetails/Effective-Responses-to-FDA-483’s-and-Warning-Le | Want to Edit it Edit Freely

    Category

    Deadline: May 19, 2017 | Date: May 19, 2017

    Venue/Country: Online

    Updated: 2017-03-10 15:19:19 (GMT+9)

    Call For Papers - CFP

    When you receive an FDA-483 after your FDA inspection, how you respond can determine if FDA will send you a Warning Letter. If you receive an FDA Warning Letter citing violations, how you respond can determine if FDA will seek a Voluntary Injunction effectively putting you out of business.

    In this webinar we will discuss the correct way to formulate your response to demonstrate to FDA that you have a complete understanding of the issues, and the corrective actions will prevent a recurrences of the violations.

    Why Should You Attend

    If your responsibility is responding to FDA-483’s and Warning Letter you must become familiar with the type of response that will satisfy FDA.Too often firms send incomplete (not well thought out) response to FDA either correcting and individual problem, not providing objective evidence, and/or providing unreasonable correction dates. It his happens with an FDA -484 FDA will either visit you again very soon, or you will get a Warning Letter. A poor response to Warning Letter can be disastrous.

    Areas Covered in this Webinar

    FDA policies on creating the FDA-483

    FDA policy on issuing Warning Letters

    Review example of Warning Letter Responses.

    How to manage the creation of an effective response

    Learning Objectives

    What is an FDA-483?

    Why does FDA issue Warning Letters?

    How do you formulate an effective response?

    Review recent FDA Warning Letter citations

    How to determine if FDA is satisfied with your response.

    Who Will Benefit

    - QA Manager, Director or VP’s

    - Regulatory Affairs Managers, Director, or VP

    - Operations Managers, Directors or VP

    - Corporate Compliance Personnel.

    - Regulatory Consultants to the medical device industry

    For More Info, Please Click below URL:

    https://www.demystifiedsolutions.com/trainingDetails/Effective-Responses-to-FDA-483’s-and-Warning-Letters-DEMY050159


    Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
    Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.